Clinical Trials Sponsored by Marcus Institute

Total 76823 results

Marcus Migura
Mercy Health

Completed

A Transparent Elasticized Adhesive Occlusive Compression Bandage for Use as an Arterial Tourniquet

Hemorrhage | Vascular Injury

United States
Marius Aliuskevicius
University of Aarhus

Completed

Non Steroidal Antiinflammatory Drugs Influence on Heal of Distal Radius Fracture (CHIP)

Forearm Fracture

Denmark
Karolinska Institutet
Marcus och Amalia Wallenbergs minnesfond

Completed

SKOLKONTAKT - Social Skills Training in a School Setting (SKOLKONTAKT)

Depression | Anxiety | Autism Spectrum Disorder | Attention Deficit Hyperactivity Disorder

Sweden
Hompesch, Marcus, M.D.
Profil Institute for Clinical Research, Inc.

Unknown

PK/PD Study of Intranasal Insulin in Type I Diabetes

Type 1 Diabetes

United States
University of Aarhus
Karolinska Institutet; Aarhus University Hospital

Completed

Internet-delivered Acceptance and Commitment Therapy for Patients With Health Anxiety

Hypochondriasis
Emory University
The Marcus Foundation

Completed

Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES) (MILES)

Osteoarthritis

United States
Duke University
The Marcus Foundation

Completed

Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder (TACT)

Autism Spectrum Disorder

United States
Marcus Malek

Withdrawn

Abdominal Wall Nerve Blockade: A Comparison With Local Port Site Injection as Well as Between the Use of Ultrasound and Laparoscopy to Guide Placement

Postoperative Pain
Marcus Van Aarsen
Lawson Health Research Institute

Unknown

The Effect of Point-of-care Ultrasound Guidance for Distal Radius Fracture Reduction

Point-of-care Ultrasound, Distal Radius Fracture

Canada
Aarhus University Hospital
Karolinska Institutet

Completed

Internet-delivered CBT for Functional Gastrointestinal Disorders (FGID) in Youth: a Single Case Experimental Design

Functional Gastrointestinal Disorders

Denmark
Emory University
The Marcus Foundation

Completed

Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS)

Sepsis

United States
Marcus Altfeld, M.D., Ph.D.
GlaxoSmithKline

Completed

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

HIV Infections

United States
Aarhus University Hospital
Karolinska Institutet

Recruiting

i-CBT Functional Gastrointestinal Disorders in Youth: the Impact of Negative Illness Understanding and Parental Illness Worries

Irritable Bowel Syndrome | Functional Gastrointestinal Disorders | Functional Abdominal Pain Syndrome

Denmark
Sao Marcos University

Completed

Physiotherapy in Postpartum After a Cesarean

Postpartum Period

Brazil
Karius, Inc.
Duke Clinical Research Institute

Completed

Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens (PICKUP)

Pneumonia, Viral | Pneumonia, Bacterial | Immunocompromised Host | Pneumonia Fungal | Pneumonia Cavitary

United States
University of Aarhus
Gødstrup Hospital; Aarhus University, Institute of Clinical Medicine

Recruiting

Prehabilitation in Prostate Cancer Patients, TelePrehabTrial

Prostate Cancer

Denmark
University of Aarhus
Karolinska Institutet; Aarhus University Hospital; Region Stockholm

Completed

Online Mindfulness for Women Treated for Breast Cancer and Men Treated for Prostate Cancer

Prostate Cancer | Anxiety Depression | Breast Cancer Female

Denmark
Marcus Saemann

Completed

Response Options to Blood Volume Monitoring in Fluid Overloaded Hemodialysis Patients (BVM-Reg)

Overhydration | Dry Weight Reduction

Austria
Marcus Saemann

Completed

Glucose Control in Pre-Diabetic Renal Transplant Patients (GCPD)

Kidney Transplantation | Impaired Glucose Tolerance

Austria
Marcus Maurer

Completed

Study on Mastocytosis for Rupatadine Treatment (SMART)

Mastocytosis

Germany
Arcus Biosciences, Inc.

Active, not recruiting

A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies (ARC-8)

Advanced Pancreatic Cancer

United States
Arcus Biosciences, Inc.

Completed

A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AB801 in Healthy Volunteers (ARC-26)

Cancer

United Kingdom
Arcus Biosciences, Inc.

Completed

A Study to Investigate the Safety of AB680 in Healthy Volunteers

Healthy Volunteers

Australia
Arcus Biosciences, Inc.

Completed

A Study to Investigate the Pharmacokinetic Profile of Oral AB680 in Healthy Volunteers

Healthy Volunteers

Australia
Arcus Biosciences, Inc.

Completed

A Study to Evaluate Immunotherapy Combinations in Participants With Gastrointestinal Malignancies

Colorectal Cancer | GastroEsophageal Cancer

United States, Australia
Arcus Biosciences, Inc.

Recruiting

A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies (ARC-27)

Advanced Cancer

United States
Arcus Biosciences, Inc.

Completed

Study to Investigate the Safety, Tolerability, and Pharmacokinetic Profile With Oral AB521 in Healthy Volunteers (ARC-14)

Healthy Participants

Netherlands
Arcus Biosciences, Inc.

Completed

A Relative Bioavailability Study and Food Effect Study of AB521 in Healthy Adult Volunteers (ARC-28)

Healthy Participants

United States
Arcus Biosciences, Inc.

Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

Melanoma | Renal Cell Carcinoma | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Squamous Cell Carcinoma of the Head and Neck | Bladder Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Castration-resistant Prostate Cancer | Merkel Cell Carcinoma | GastroEsophageal Cancer

United States, Australia
Arcus Biosciences, Inc.

Completed

A Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetic Profile of Etrumadenant in Healthy Adult Participants

Healthy Participants

United States
Instituto de Investigación Marqués de Valdecilla

Recruiting

A Population-based Cohort in Northern Spain (COHORTE)

Chronic Disease

Spain
Instituto de Investigación Marqués de Valdecilla

Recruiting

Cost-effectiveness of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care (PsicAP-Costs2)

Emotional Disorder

Spain
Instituto de Investigación Marqués de Valdecilla

Recruiting

Efficacy and Safety of Endoscopic Sleeve Gastroplasty Versus Laparoscopic Sleeve Gastrectomy in Obese Subjects With NASH (TESLA-NASH)

Non-alcoholic Steatohepatitis (NASH)

Spain
Pfizer
Karolinska Institutet; University of Aarhus

Completed

Varenicline Pregnancy Cohort Study

Malformations
Instituto de Investigación Marqués de Valdecilla

Terminated

TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTA (IDI-HTA2020)

Arterial Hypertension | Diet Habit | Sodium Urine | Primary Care Center

Spain
Instituto de Investigación Marqués de Valdecilla

Withdrawn

Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection

COVID 19 | Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors
Instituto de Investigación Marqués de Valdecilla

Unknown

Minimally Invasive Right Colectomy Anastomosis Study (MIRCAST)

Colorectal Cancer | Colectomy | Anastomotic Complication

Spain, Finland, Germany, Italy, Croatia, Denmark, France, Greece, Portugal, United Kingdom
Instituto de Investigación Marqués de Valdecilla

Unknown

A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures (HONEST)

Mental Disease | Hepatotropic Virus Infection | Addictive Behaviours o Conducts | People Sentenced to Non-custodial Sentences

Spain
Instituto de Investigación Marqués de Valdecilla

Recruiting

Big Data Analysis of OSA Patients on Positive Airway Pressure (PAP) Treatment: Real-life Monitoring (TeleVAL)

Obstructive Sleep Apnea | Positive Airway Pressure

Spain
Instituto de Investigación Marqués de Valdecilla

Withdrawn

Efficacy, Safety, and Immunogenicity of Vaccine Reimmunization With a Third Homologous Versus Heterologous Dose Against COVID-19 in Patients Undergoing Solid Organ Transplantation. (REIN-TX)

Covid19

Spain
Instituto de Investigación Marqués de Valdecilla

Unknown

Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET) (SARIPET)

Rheumatoid Arthritis | Atherosclerosis
Instituto de Investigación Marqués de Valdecilla

Unknown

Endoscopic Bariatric Therapy in NASH Cirrhosis (ETHIC)

Non-alcoholic Steatohepatitis (NASH)
Instituto de Investigación Marqués de Valdecilla

Completed

Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) (PREVHEP)

Hepatitis B | Hepatitis C

Spain
Aarhus University Hospital
Statens Serum Institut

Completed

Cohabitation Patterns and Incidence of Known and Suspected Sexually Transmitted Diseases

Sexually Transmitted Diseases | Cohabitation Patterns
University of Aarhus
Statens Serum Institut

Completed

Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar (FGS/MGS/STI)

Sexually Transmitted Infections | Schistosoma Haematobium

Madagascar
Yale University
National Cancer Institute (NCI); Arcus Biosciences, Inc.

Recruiting

AB154 Combined With AB122 for Recurrent Glioblastoma

Glioblastoma

United States
EarliTec Diagnostics, Inc
Marcus Autism Center

Recruiting

Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD) For Children Ages 31-84 Months (MEASURE-ASD2)

Autism Spectrum Disorder | Autism

United States
Emory University
The Marcus Foundation, Inc.

Recruiting

Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis

United States
EarliTec Diagnostics, Inc
Marcus Autism Center

Recruiting

Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children (MEASURE-ASD1)

Autism Spectrum Disorder | Developmental Delay | Autism | Autism, Early Infantile | Autism, Infantile

United States
Marcus Maurer
Charite University, Berlin, Germany

Terminated

Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria (MIARCU)

Chronic Urticaria

Germany

Clinical Trials Sponsored by Marcus Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations